Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer. - Fetscher,S.; Brugger,W.; Engelhardt,R. (Ann Oncol, 1997)